ClinicalTrials.govpublic full text
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma
advanced hepatocellular carcinoma, hepatocellular carcinoma, liver cancer, liver neoplasms, hepatic cancer, hepatic carcinoma, h3b-6527, fibroblast growth factor receptor 4 (fgfr4), fibroblast growth factor 19 (fgf19), interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 856882
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.